Publications | Page 12 | Cervo Brain Research Centre

Export 16 results:

Filters: Author is Dupré, Nicolas [Clear All Filters]

2022

“Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis.”, JAMA Neurol, vol. 79, no. 2, pp. 185-193, 2022.

“Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.”, PLoS One, vol. 17, no. 2, p. e0263108, 2022.

2021

A. Giguère-Rancourt, Plourde, M., Racine, E., Couture, M., Langlois, M., Dupré, N., and Simard, M., “Altered Theory of Mind in Parkinson's Disease and Impact on Caregivers: A Pilot Study.”, Can J Neurol Sci, pp. 1-4, 2021.

2020

Z. Gan-Or, Rao, T., Leveille, E., Degroot, C., Chouinard, S., Cicchetti, F., Dagher, A., Das, S., Desautels, A., Drouin-Ouellet, J., Durcan, T., Gagnon, J. - F., Genge, A., Karamchandani, J., Lafontaine, A. - L., Sun, S. Lai Wing, Langlois, M., Lévesque, M., Melmed, C., Panisset, M., Parent, M., Poline, J. - B., Postuma, R. B., Pourcher, E., Rouleau, G. A., Sharp, M., Monchi, O., Dupré, N., and Fon, E. A., “The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.”, J Parkinsons Dis, vol. 10, no. 1, pp. 301-313, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.

2019

J. Lamontagne-Proulx, St-Amour, I., Labib, R., Pilon, J., Denis, H. L., Cloutier, N., Roux-Dalvai, F., Vincent, A. T., Mason, S. L., Williams-Gray, C., Duchez, A. - C., Droit, A., Lacroix, S., Dupré, N., Langlois, M., Chouinard, S., Panisset, M., Barker, R. A., Boilard, E., and Cicchetti, F., “Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.”, Neurobiol Dis, vol. 124, pp. 163-175, 2019.

2018

M-A Roy, Doiron, M., Talon-Croteau, J., Dupré, N., and Simard, M., “Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review.”, Can J Neurol Sci, vol. 45, no. 4, pp. 375-404, 2018.

A. Giguère-Rancourt, Plourde, M., Doiron, M., Langlois, M., Dupré, N., and Simard, M., “Goal management training ® home-based approach for mild cognitive impairment in Parkinson's disease: a multiple baseline case report.”, Neurocase, vol. 24, no. 5-6, pp. 276-286, 2018.

M. Doiron, Langlois, M., Dupré, N., and Simard, M., “The influence of vascular risk factors on cognitive function in early Parkinson's disease.”, Int J Geriatr Psychiatry, vol. 33, no. 2, pp. 288-297, 2018.

B. Paré, Lehmann, M., Beaudin, M., Nordström, U., Saikali, S., J-P Julien, Gilthorpe, J. D., Marklund, S. L., Cashman, N. R., Andersen, P. M., Forsberg, K., Dupré, N., Gould, P., Brännström, T., and Gros-Louis, F., “Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis.”, Sci Rep, vol. 8, no. 1, p. 14223, 2018.

2017

M. Doiron, Dupré, N., Langlois, M., Provencher, P., and Simard, M., “Smoking history is associated to cognitive impairment in Parkinson's disease.”, Aging Ment Health, vol. 21, no. 3, pp. 322-326, 2017.

2016

V. Picher-Martel, Valdmanis, P. N., Gould, P. V., J-P Julien, and Dupré, N., “From animal models to human disease: a genetic approach for personalized medicine in ALS.”, Acta Neuropathol Commun, vol. 4, no. 1, p. 70, 2016.

2012

J. Zhao, Dupré, N., Puymirat, J., and Chahine, M., “Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians.”, J Physiol, vol. 590, no. 11, pp. 2629-44, 2012.

2011

V. Swarup, Phaneuf, D., Dupré, N., Petri, S., Strong, M., Kriz, J., and J-P Julien, “Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.”, J Exp Med, vol. 208, no. 12, pp. 2429-47, 2011.

2009

F. Gros-Louis, Andersen, P. M., Dupré, N., Urushitani, M., Dion, P., Souchon, F., D'Amour, M., Camu, W., Meininger, V., Bouchard, J. - P., Rouleau, G. A., and J-P Julien, “Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 106, no. 51, pp. 21777-82, 2009.

Funding / Support / Partners

© Gouvernement du Québec